News
Companies have scant financial incentive to develop new antibiotics. Will the NIH continue to support relevant research?
Billions of dollars of National Institutes of Health research were stuck in limbo for hours, causing confusion after a memo ...
Key context: Typically, NIH research grants are awarded for multiple years and funded incrementally. The change to ...
NIH plans to shrink the share of grant applications it will award for the remainder of the fiscal year, in some cases by more ...
A PhD candidate and Winter Park High School graduate discusses what losing science funding would hurt for them and the world ...
NIH budget cuts are threatening key medical research programs, shrinking training grants, and leaving young researchers facing career uncertainty.
The president's proposed budget cuts to the NIH would eventually result in fewer drugs on the market, the U.S. Congressional ...
U.S. investment in new treatments is often driven by market potential rather than medical necessity, deepening health ...
Food and Drug Administration Commissioner Marty Makary has taken a personal interest in addressing hormone therapy treatment for menopause.
Mark Cuban challenges the idea that high drug prices are necessary for R&D, PBMs take away from profits, leaving less for ...
Venture Partners at CU Boulder has announced the first recipients of a new translational funding program designed to advance promising, early-stage therapeutics with strong commercial potential. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results